CUL4A, which has the highest homolog with CUL4B, is overexpressed in primary breast cancers [25, 26] and hepatocellular carcinomas [27], and overexpression of CUL4A is associated with poor outcome in node-negative breast cancer [28]. Here, CUL4B is linked to breast cancer.